Difelikefalin for pruritus associated with chronic kidney disease.
出版信息
Aust Prescr. 2024 Aug;47(4):132-133. doi: 10.18773/austprescr.2024.032.
Abstract
摘要
相似文献
1
Difelikefalin for pruritus associated with chronic kidney disease.地法林用于治疗与慢性肾脏病相关的瘙痒。
Aust Prescr. 2024 Aug;47(4):132-133. doi: 10.18773/austprescr.2024.032.
2
Difelikefalin: First Approval.地氟烷：首次批准。
Drugs. 2021 Nov;81(16):1937-1944. doi: 10.1007/s40265-021-01619-6.
3
Difelikefalin: A New κ-Opioid Receptor Agonist for the Treatment of Hemodialysis-Dependent Chronic Kidney Disease-Associated Pruritus.地氟烷啡肽：一种新型 κ-阿片受体激动剂，用于治疗血液透析依赖的慢性肾脏病相关性瘙痒。
Ann Pharmacother. 2023 Apr;57(4):480-488. doi: 10.1177/10600280221115889. Epub 2022 Aug 9.
4
Difelikefalin in the Treatment of Chronic Kidney Disease-Associated Pruritus: A Systematic Review.地肤利法林治疗慢性肾脏病相关性瘙痒：一项系统评价
Pharmaceuticals (Basel). 2022 Jul 28;15(8):934. doi: 10.3390/ph15080934.
5
Impact of Difelikefalin on the Health-Related Quality of Life of Haemodialysis Patients with Moderate-To-Severe Chronic Kidney Disease-Associated Pruritus: A Single-Arm Intervention Trial.地氟烷啡肽对中重度慢性肾脏病相关瘙痒的血液透析患者健康相关生活质量的影响：一项单臂干预试验。
Patient. 2024 Mar;17(2):203-213. doi: 10.1007/s40271-023-00668-1. Epub 2024 Jan 9.
6
Difelikefalin (Korsuva) for chronic kidney disease-associated pruritus.地夫可法林（Korsuva）用于治疗慢性肾脏病相关性瘙痒。
Med Lett Drugs Ther. 2022 Feb 7;64(1643):18-19.
7
A phase 2 study of oral difelikefalin in subjects with chronic kidney disease and moderate-to-severe pruritus.口服地福来碱治疗慢性肾脏病伴中重度瘙痒患者的 2 期研究。
J Am Acad Dermatol. 2023 Aug;89(2):261-268. doi: 10.1016/j.jaad.2023.03.051. Epub 2023 Apr 12.
8
Difelikefalin for the treatment of moderate-to-severe pruritus associated with chronic kidney disease on hemodialysis.地肤利法林用于治疗血液透析的慢性肾病相关的中重度瘙痒。
Expert Rev Clin Pharmacol. 2023 May;16(5):387-400. doi: 10.1080/17512433.2023.2197209. Epub 2023 Apr 13.
10
Randomized Controlled Trial of Difelikefalin for Chronic Pruritus in Hemodialysis Patients.地氟可特林用于血液透析患者慢性瘙痒的随机对照试验。
Kidney Int Rep. 2020 Jan 28;5(5):600-610. doi: 10.1016/j.ekir.2020.01.006. eCollection 2020 May.
本文引用的文献
1
Alleviating symptoms in patients undergoing long-term hemodialysis: a focus on chronic kidney disease-associated pruritus.缓解长期血液透析患者的症状：聚焦于慢性肾脏病相关性瘙痒
Clin Kidney J. 2022 Aug 24;16(1):30-40. doi: 10.1093/ckj/sfac187. eCollection 2023 Jan.
2
Safety and Tolerability of Difelikefalin for the Treatment of Moderate to Severe Pruritus in Hemodialysis Patients: Pooled Analysis From the Phase 3 Clinical Trial Program.地肤可法林治疗血液透析患者中重度瘙痒的安全性和耐受性：3期临床试验项目的汇总分析
Kidney Med. 2022 Jun 28;4(8):100513. doi: 10.1016/j.xkme.2022.100513. eCollection 2022 Aug.
3
Efficacy of Difelikefalin for the Treatment of Moderate to Severe Pruritus in Hemodialysis Patients: Pooled Analysis of KALM-1 and KALM-2 Phase 3 Studies.地氟来法林治疗血液透析患者中重度瘙痒的疗效：KALM-1和KALM-2 3期研究的汇总分析。
Kidney Med. 2022 Jun 28;4(8):100512. doi: 10.1016/j.xkme.2022.100512. eCollection 2022 Aug.
4
Self-reported Pruritus and Clinical, Dialysis-Related, and Patient-Reported Outcomes in Hemodialysis Patients.血液透析患者的自我报告瘙痒及临床、透析相关和患者报告结局
Kidney Med. 2020 Nov 21;3(1):42-53.e1. doi: 10.1016/j.xkme.2020.08.011. eCollection 2021 Jan-Feb.
5
Interventions for itch in people with advanced chronic kidney disease.晚期慢性肾脏病患者的瘙痒干预措施。
Cochrane Database Syst Rev. 2020 Dec 7;12(12):CD011393. doi: 10.1002/14651858.CD011393.pub2.
Zotero 插件